Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Tax Withholding | 2024-04-02 4:59 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 14,052 | $5.12 | 222,792 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:59 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 45,566 | $0 | 222,792 (Direct) | View |
| 2023-12-14 Disposition | 2023-12-15 6:46 pm | N/A N/A | Seagen Inc. | SGEN | Simonian Nancy A Director | 62,753 | $229 | 0 (Direct) | View |
| 2023-12-14 Disposition | 2023-12-15 6:46 pm | N/A 2024-05-16 | Seagen Inc. | SGEN | Simonian Nancy A Director | 65,181 | $0 | 0 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 5:23 pm | N/A 2026-09-15 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 112,798 | $0 | 0 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 13,401 | $2.22 | 140,269 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 40,125 | $0 | 140,269 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 6:20 pm | N/A N/A | Seagen Inc. | SGEN | Simonian Nancy A Director | 2,044 | $0 | 64,797 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 6:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 6,000 | $0 | 91,420 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-04 6:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 1,852 | $2.58 | 91,420 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:17 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 118,700 | $0 | 118,700 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 5:49 pm | N/A N/A | Seagen Inc. | SGEN | Simonian Nancy A Director | 8,750 | $36.7 | 62,753 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 5:49 pm | N/A 2023-05-17 | Seagen Inc. | SGEN | Simonian Nancy A Director | 8,750 | $0 | 62,753 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:36 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 195,250 | $0 | 195,250 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 7:28 pm | 2023-05-13 2032-05-13 | Seagen Inc. | SGEN | Simonian Nancy A Director | 5,179 | $0 | 57,679 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:02 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 58,883 | $1.12 | 692,723 (Direct) | View |
| 2022-03-02 Exercise | 2022-03-04 5:09 pm | N/A 2022-03-19 | Seagen Inc. | SGEN | Simonian Nancy A Director | 25,000 | $0 | 52,500 (Direct) | View |
| 2022-03-02 Exercise | 2022-03-04 5:09 pm | N/A N/A | Seagen Inc. | SGEN | Simonian Nancy A Director | 25,000 | $20.04 | 52,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:05 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 1,015,000 | $0 | 1,015,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 7:35 pm | 2022-05-14 2031-05-14 | Seagen Inc. | SGEN | Simonian Nancy A Director | 4,864 | $0 | 30,962 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:10 pm | N/A 2031-02-16 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 304,000 | $0 | 304,000 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-21 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 14,168 | $8.51 | 944,307 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-21 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 10,761 | $3.04 | 944,307 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-21 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 4,988 | $10.09 | 944,307 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-21 4:58 pm | N/A 2025-06-08 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 29,917 | $0 | 944,307 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 5:14 pm | N/A 2030-06-17 | Evelo Biosciences Inc. | EVLO | Simonian Nancy A Director | 15,690 | $0 | 15,690 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 7:11 pm | 2021-05-15 2030-05-15 | SEATTLE GENETICS INC | SGEN | Simonian Nancy A Director | 4,506 | $0 | 29,269 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-14 4:04 pm | N/A 2030-02-12 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 294,000 | $0 | 294,000 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-23 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 52,401 | $3.04 | 3,615,240 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-23 4:54 pm | N/A 2024-02-04 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 52,401 | $0 | 3,615,240 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-13 08:28 am | N/A 2029-06-12 | Evelo Biosciences Inc. | EVLO | Simonian Nancy A Director | 15,690 | $0 | 15,690 (Direct) | View |
| 2019-05-20 Option Award | 2019-05-22 9:44 pm | N/A 2029-05-20 | SEATTLE GENETICS INC | SGEN | Simonian Nancy A Director | 10,001 | $0 | 31,801 (Direct) | View |